Cargando…

Comparison of Contemporary Drug-Eluting Stents in Patients Undergoing Complex High-Risk Indicated Procedures

BACKGROUND: Limited data are available on the relative performances of diverse contemporary drug-eluting stents (DES) in patients undergoing complex high-risk indicated procedures (CHIP). OBJECTIVES: The purpose of this study was to evaluate the comparative effectiveness of contemporary second-gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Yeong Jin, Hyun, Junho, Lee, Junghoon, Kim, Ju Hyeon, Yang, Yujin, Choe, Kyungjin, Lee, Ji Sung, Park, Hanbit, Cho, Sang-Cheol, Kang, Do-Yoon, Lee, Pil Hyung, Ahn, Jung-Min, Park, Duk-Woo, Park, Seung-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627895/ https://www.ncbi.nlm.nih.gov/pubmed/36339122 http://dx.doi.org/10.1016/j.jacasi.2021.10.008

Ejemplares similares

Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus
por: Yang, Yujin, et al.
Publicado: (2021)

Ten‐year Outcomes After Drug‐Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow‐Up Study
por: Jeong, Yeong Jin, et al.
Publicado: (2021)

Prognostic Effect of the SYNTAX Score on 10‐Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial
por: Lee, Junghoon, et al.
Publicado: (2021)

Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
por: Park, Hanbit, et al.
Publicado: (2021)

Two Cases of Immediate Stent Fracture after Zotarolimus-Eluting Stent Implantation
por: Lee, Pil Hyung, et al.
Publicado: (2015)

Time‐Dependent Impact of Sex on the Long‐Term Outcomes After Left Main Revascularization
por: Yoon, Yong‐Hoon, et al.
Publicado: (2022)

Comparison of Different Types of Drug-Eluting Stents for De Novo Long Coronary Artery Lesions
por: Kang, Do-Yoon, et al.
Publicado: (2022)

Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
por: Kang, Se Hun, et al.
Publicado: (2017)

Prognostic Value of Sex After Revascularization for Left Main Coronary Disease: Extended PRECOMBAT Study
por: Yang, Yujin, et al.
Publicado: (2021)

Long‐Term (7‐Year) Clinical Implications of Newly Unveiled Asymptomatic Abnormal Ankle–Brachial Index in Patients With Coronary Artery Disease
por: Lee, Jong‐Young, et al.
Publicado: (2021)

Long‐Term (10‐Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus
por: Lee, Kyusup, et al.
Publicado: (2020)

Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Song, Pil Sang, et al.
Publicado: (2018)

Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea
por: Kwon, Osung, et al.
Publicado: (2018)

Practical based approach to left main bifurcation stenting
por: Ahn, Jung-Min, et al.
Publicado: (2016)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation
por: Lee, Hye Won, et al.
Publicado: (2013)

Acute and Long-Term Angiographic Outcomes of Side Branch Stenosis after Randomized Treatment of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stent for Coronary Artery Stenosis
por: Lee, Bong-Ki, et al.
Publicado: (2012)

Impact of the ultra‐long 48 mm drug‐eluting stent on procedural and clinical outcomes in patients with diffuse long coronary artery disease
por: Youn, Young Jin, et al.
Publicado: (2023)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
por: Park, Soonchan, et al.
Publicado: (2013)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
por: Condello, Francesco, et al.
Publicado: (2023)

Assessment of anti-dislodgment capability for contemporary drug eluting stents
por: Ye, Yicong, et al.
Publicado: (2021)

Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
por: Park, Jong-Il, et al.
Publicado: (2022)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
por: Yin, Juntao, et al.
Publicado: (2023)

Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011)

Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
por: Cho, Min Soo, et al.
Publicado: (2017)

Differential Clinical Benefit With Contemporary Drug-Eluting Stents: Fact or Fancy?
por: Kereiakes, Dean J.
Publicado: (2022)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Practice Pattern, Diagnostic Yield, and Long‐Term Prognostic Impact of Coronary Computed Tomographic Angiography
por: Cho, Min Soo, et al.
Publicado: (2020)

Clinical Impact of Lesion Complexity on 2-Year Outcomes After Zotarolimus-Eluting Stents Implantation
por: Park, Jung-Ho, et al.
Publicado: (2021)

Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients
por: Cha, Jung-Joon, et al.
Publicado: (2022)

Efficacy of Triple Anti-Platelet Therapy Including Cilostazol in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stent Implantation
por: Park, Keun-Ho, et al.
Publicado: (2009)

Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?
por: Chang, Mineok, et al.
Publicado: (2014)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea
por: Lee, Joo Myung, et al.
Publicado: (2013)

Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
por: Tantawy, Ayman, et al.
Publicado: (2017)

Impact of Complete or Incomplete Revascularization for Left Main Coronary Disease: The Extended PRECOMBAT Study
por: Kim, Taesun, et al.
Publicado: (2023)

Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis
por: Choi, Hong Sang, et al.
Publicado: (2011)

A Comparison of Two Brands of Clopidogrel in Patients With Drug-Eluting Stent Implantation
por: Park, Yae Min, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4330ih6ce8qveanam137rj7i05